Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marel Director's Dealing 2021

May 5, 2021

2191_rns_2021-05-05_aed19d87-ab5d-4920-bbf8-d0ab75dd3767.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEDLABAT 1. SLANDS

FJÁRMÁLA EFTIRLIT

Viðskipti fruminnerja/

Transaction of primary insider

Auðkenni útgefanda/Trade ticker:
MAREL

Nafn útgefanda/Issuer:
Marel hf.

Dagsetning tilkynningar/Date of announcement:
5.5.2021

Nafn fruminnerja/Name primary insider:
Árni Sigurðsson

Tengsl fruminnerja við útgefanda/Insider's relation with the issuer:
Framkvæmdastjóri stefnumótunar og stefnumarkandi rekstrareininga / Chief Strategy Officer

Dagsetning viðskipta/Date of transaction:
5.5.2021

Tímaseting viðskipta/Time of transaction:
0

Tegund fjármálagernings/Type of financial instrument:
Hlutabréf / Equities

Kaup eða sala/Buy or Sell:
Kaup/Buy

Fjöldi hluta/Number of shares:
251.933

Verð pr. Hlut/Price per share:
EUR 2,374

Fjöldi hluta í eigu fruminnerja eftir viðskipti/Primary insider's holdings after the transaction:
369.250

Fjöldi hluta sem fruminnerji á kauprétt að/Primary insider's option holdings after the transaction:
1.340.000

Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties' holdings after the transaction:
100.000

Dagsetning lokauppgjørs/Date of settlement:
0

Athugasemdir/Comments:
Viðskiptin eru til að mæta skilyrðum um framkvæmd kaupréttarsamninga. Kaupréttirnir voru veittir árin 2014 og 2018 á grundvelli starfskjarastefnu félagsins eins og hún var samþykkt af aðalfundi á hverjum tíma.
Fruminnerjinn keypti 90.000 hluti á kaupréttargenginu 0,775 evrur á hlut í samræmi við kaupréttarsamning frá árinu 2014. Móttekin bréf fruminnerja nema að öðru leyti mismun á kaupréttargengi vegna samnings frá árinu 2018 sem var 2,713 evrur á hlut og dagslokagengi á Euronext Amsterdam þann 4. maí 2021, hvort tveggja


FJÁRMÁLA EFTIRLIT

margfaldað með fjölda nýttra kaupréttta vegna samnings frá árinu 2018 sem voru 425.000, að frádregnum sköttum.

Uppgefið kaupverð á hlut er vegið meðaltal kaupverðs allra nýttra kaupréttta sem voru samtals 515.000.

Transaction to fulfill obligations of stock option agreements. The stock options were granted in the years 2014 and 2018 in accordance with the Company's Remuneration Policy as approved at the Company's respective AGMs. The Primary insider purchased 90,000 shares at the exercise price of EUR 0.775 per share according to a stock option agreement entered into in 2014. Remaining shares received equal the difference of the exercise price of the stock options granted in 2018 (EUR 2.713 per share) and closing price on Euronext Amsterdam on 4 May 2021, both numbers multiplied with the number of exercised stock options granted in 2018 which were 425,000, less taxes.

The disclosed purchase price per share is the weighted average purchase price of all exercised stock options which were 515,000.